Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas

Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis

(2010)   HEPATOLOGY RESEARCH

Adiponectin—It's all about the modifications

(2010) Fiona Simpson et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease

(2010) S. Kaser et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?

(2010) Joshua R. Cook et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin

(2010) Stergios A. Polyzos et al.   MEDICAL HYPOTHESES

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis

(2010) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines

(2009) Stergios Polyzos et al.   CURRENT MOLECULAR MEDICINE

The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease

(2009) Stergios A. Polyzos et al.   DIABETES OBESITY & METABOLISM

Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization

(2009) Juichi Fukushima et al.   HEPATOLOGY RESEARCH